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Mesenchymal stem cells (MSCs) senescence is an age-related process that impairs
the capacity for tissue repair and compromises the clinical use of autologous MSCs
for tissue regeneration. Here, we describe the effects of SIRT1, a NAD+-dependent
deacetylase, on age-related MSCs senescence. Knockdown of SIRT1 in young MSCs
induced cellular senescence and inhibited cell proliferation whereas overexpression of
SIRT1 in aged MSCs reversed the senescence phenotype and stimulated cell proliferation.
These results suggest that SIRT1 plays a key role in modulating age-induced MSCs
senescence. Aging-related proteins, P16 and P21 may be downstream effectors of the
SIRT1-mediated anti-aging effects. SIRT1 protected MSCs from age-related DNA damage,
induced telomerase reverse transcriptase (TERT) expression and enhanced telomerase
activity but did not affect telomere length. SIRT1 positively regulated the expression
of tripeptidyl peptidase 1 (TPP1), a component of the shelterin pathway that protects
chromosome ends from DNA damage. Together, the results demonstrate that SIRT1
quenches age-related MSCs senescence by mechanisms that include enhanced TPP1
expression, increased telomerase activity and reduced DNA damage.
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INTRODUCTION
Mesenchymal stem cells (MSCs) are thought to play important
roles in tissue regeneration and repair. This can be handicapped
by age-dependentMSCs senescence and loss of function. Previous
studies have described an age-dependent decline ofMSCs levels in
bone marrow and adipose tissue (Stolzing et al., 2008; Alt et al.,
2012). Aging negatively affects MSCs proliferation and differenti-
ation including osteogenesis and chondrogenesis (Stolzing et al.,
2008; Zhou et al., 2008; Alt et al., 2012). These aging-induced loss
of MSCs number and function may be related to the fact that the
population of senescent cells shows an age-dependent increase in
the stem cell pool (Stolzing et al., 2008; Zhou et al., 2008; Alt
et al., 2012). Recent studies indicate that cellular senescencemight
inhibit cancer early in life but drive age-related phenotypes and
associated pathologies later in life (Campisi, 2013; Sikora, 2013).
From this perspective, studies focused on age-relatedMSCs senes-
cence might shed more light on mechanisms of organismal aging
and aging-related disease. More importantly, it could potentially
provide solutions to reverse or prevent MSCs aging processes.
Sir2p, a NAD+-dependent protein deacetylase has been shown
to regulate longevity in lower organisms (Frye, 2000), but it is
unclear whether SIRT1, the mammalian homolog of Sir2p, has
the same effect in humans (Houtkooper et al., 2012). A growing
body of evidence suggests that elevated SIRT1 activity can have
beneficial effects on aging and aging-related diseases in mammals
(Herranz and Serrano, 2010; Herranz et al., 2010; Herskovits
and Guarente, 2014). These actions may be related to SIRT1-
mediated modulation of DNA and metabolic damage (Herranz
et al., 2010; Herranz and Serrano, 2010). Roles for SIRT1 in
preventing endothelial cells from replicative senescence or stress-
induced premature senescence (SIPS) have been reported recently
(Ota et al., 2007; Zu et al., 2010). These anti-aging effects were
associated with deacetylation of LKB1 (Zu et al., 2010) or P53
(Ota et al., 2007) by SIRT1. SIRT1 was also shown to protect
human umbilical cord fibroblasts from replicative senescence by
promoting the transcription of telomerase reverse transcriptase
(TERT) (Yamashita et al., 2012). More recently, it was reported
that SIRT1 could mitigate the replicative senescence of young
MSCs in vitro (Yuan et al., 2012). Therefore we postulated here
that age-induced biological changes of adult MSCs is driven at
least in part by SIRT1.
Therefore, in the present study, we aimed to investigate: first,
whether the aging process of MSCs is associated with a down-
regulated expression of SIRT1 and whether over-expression of
SIRT1 would reverse the phenotype of the age-related MSCs
senescence; second, whether cyclin-dependent kinase (CDK)
regulators, including P16INK4A (P16) and P21WAF1 (P21) are
involved in the aging process ofMSCs and act as the keymediators
of SIRT1 activity through which TPP1 plays the key roles in medi-
ating telomerase function and protects against DNA damage.
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MATERIALS AND METHODS
ANIMALS
The male Sprague-Dawley (SD) rats were obtained from College
of Life Sciences, Zhejiang University (Hangzhou, China). All
protocols were approved by the Animal Ethics Committee of
Zhejiang University and conformed with the Guide for the Care
and Use of Laboratory Animals published by the US National
Institute of Health (NIH Publication No. 85-23, revised 1996).
ISOLATION AND CULTURE OF MSCs
Bone marrow cells (BMCs) were harvested according to the pro-
tocol of Scutt et al. (Scutt and Bertram, 1995) and MSCs were
isolated by methods described previously (Galderisi et al., 2009).
Briefly, young (4-week-old) (Stolzing and Scutt, 2006; Khan et al.,
2011) and aged (18-month-old) (Khan et al., 2011) male rats
were sacrificed and BMCs were obtained by flushing tibias and
femurs with culture solution (DMEM supplemented with 10%
FBS (Life Technologies, Paisley, UK), 100U/ml penicillin, and
100U/ml streptomycin). Cells from one rat were inoculated into
two 100-mm dishes with culture solution and non-adherent cells
were removed 24 h later. Culture medium was replaced every 3–4
days and the cells were passaged at 70–80% confluence. MSCs at
passage 2–5 were used in the following experiments.
ADIPOGENIC AND OSTEOGENIC DIFFERENTIATION OF MSCs
For adipogenic differentiation, the MSCs were cultured in
high-glucose DMEM supplemented with 10% FBS, 1μM
dexamethasone, 10μM insulin, 200μM indomethacin and
0.5mM isobutyl-methylxanthine for 2 weeks (Wu et al., 2010).
Differentiated MSCs were evaluated by Oil red O stain-
ing. For osteogenic differentiation, the MSCs were cultured
in low-glucose DMEM supplemented with 10% FBS, 10mM
β-glycerophosphate, 50μg/ml of α-ascorbic acid, and 0.1μM
dexamethasone for 2 weeks (Li et al., 2011). Differentiated MSCs
were identified by alkaline phosphatase staining.
FLOW CYTOMETRY ANALYSIS
For flow cytometry analysis, young or aged MSCs at passage 3
were washed with phosphate buffered solution (PBS) and labeled
for 30min at 4◦C with CD29 (eBioscience, San Diego, CA,
USA), CD44H (BD Biosciences, San Jose, CA, USA), CD73 (BD
Biosciences, San Jose, CA, USA), CD90.1 (eBioscience, San Diego,
CA, USA), CD105 (Abcam, Cambridge, UK), CD31 (Abcam,
Cambridge, UK), CD34 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), and CD45 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) antibodies. After washing cells with PBS, cells were analyzed
on BD FACSCanto II flow cytometer (BD Biosciences, San Jose,
CA, USA).
LENTIVIRAL VECTOR CONSTRUCTION, VIRUS PRODUCTION, AND
INFECTION
Recombinant lentiviruses containing shRNA against SIRT1
and nonsense shRNA were purchased from Shanghai Sunbio
Medical Biotechnology (Shanghai, China). The target sequence
for SIRT1 was 5′- GCAGATTAGTAAGCGTCTT -3′ and the
negative control sequence was 5′-TTCTCCGAACGTGTCACGT-
3′. The lentiviral vector expressing SIRT1 (pLVX-SIRT1-EGFP-
3FLAG-Puro) was constructed by cloning the SIRT1 gene into
the pLVX-EGFP-3FLAG-Puro vector via EcoRI site, which was
also from Shanghai Sunbio Medical Biotechnology (Shanghai,
China). The SIRT1 cDNA was amplified using the follow-
ing primers: Forward: 5′- CTCAAGCTTCGAATTCGCCACCAT
GGTTGTCGCGTCGCTG-3′, Reverse: 5′-CCATGGTGGCGAAT
TCATAGTGCTCTGATTTGTCTGGTG-3′.
Viral supernatants was produced in HEK293T cells after
cotransfection of pLVX-SIRT1-EGFP-3FLAG-Puro or pLVX-
EGFP-3FLAG-Puro vector with the packaging plasmid psPAX2
and the envelope plasmid pMD2.G using Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA). The supernatant was harvested
at 72 h post transfection, filtered through Millex-HV 0.45μm
PVDF filter (Millipore, Billerica, MA, USA), and stored at −80◦C
until use.
Passages 2–3 of MSCs were infected with the purified
lentivirus overnight at the multiplicities of infection (MOI) of
10 with 8μg/ml polybrene and the medium was replaced with
fresh growth medium the day after infection. After puromycin
(5μg/ml) selection, the infection efficiency was determined by
EGFP expression. The levels of SIRT1 expression were detected
by western blot.
SENESCENCE-ASSOCIATED β-GALACTOSIDASE (SA-β-GAL) ASSAY
SA-β-gal staining was conducted with senescence β-galactosidase
staining kit (Beyotime Institute of Biotechnology, Shanghai,
China) per the manufacturer’s instructions. Briefly, MSCs were
washed with PBS and then fixed with 4% formaldehyde. After
washing with PBS, the cells were incubated at 37◦C overnight
in a humidified chamber with SA-β-gal staining solution. The
next day, the cells were washed again in PBS and the percent of
senescent cells was examined under the microscope.
CELLULAR PROLIFERATION TEST
Cellular proliferation was determined by Cell Counting Kit-8
(CCK-8) (Bestbio, Shanghai, China) according to manufacturer’s
protocols. In brief, 100μl cell suspension (2000 MSCs) with 15%
FBS was added into 96-well plate. At 0, 1, 2, 3, 4, and 5 days, 10μl
CCK8 solution was added to each well. After incubate for 3 h at
37◦C, the absorbance was measured at 450 nm by a microplate
reader (Bio-Rad, Berkeley, CA, USA).
TELOMERE LENGTH MEASUREMENT BY REAL-TIME PCR
The method measuring telomere length with real-time PCR
was reported previously (Peng et al., 2011). Genomic DNA
was extracted on the basis of the manufacturer’s instrc-
tions (Aidlab, Beijing, China). Quantitative RT-PCR was con-
ducted using SYBR Green Reaction Mix (TaKaRa, Dalian,
China) according to the manufacturer’s instructions on an
ABI PRISM 7900 HT Detection System (Applied Biosystems,
Carlsbad, CA, USA). The primers were as follow (Peng et al.,
2011): Telomere forward primer 5′-GGTTTTTGAGGGTGAGGG
TGAGGGTGAGGGTGAGGGT-3′, reverse primer 5′-TCCCGAC
TATCCCTATCCCTATCCCTATCCCTATCCCTA-3′. The refer-
ence gene 36B4: forward primer 5′-CTCACTCCATCATCAAT
GGATACAA-3′, reverse primer 5′-CAGCCAGTGGGAAGGT
GTAGTCA-3′. PCR conditions were 95◦C for 30 s followed by 40
cycles of 95◦C for 5 s and 56◦C for 31 s (Peng et al., 2011). The
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single-copy gene 36B4 was used as a control and the target gene
expression was calculated using the Ct comparative method.
QUANTITATIVE REAL-TIME PCR
Total RNA was isolated from MSCs using Trizol reagent
(Invitrogen, Carlsbad, CA, USA) per the manufacturer’s instruc-
tions. The cDNA was synthesized from 1μg of RNA using
Moloney Murine Leukemia Virus (M-MLV) reverse transcrip-
tase and oligo (dT) 18 primer (TaKaRa, Dalian, China).
Quantitative RT-PCR was conducted using SYBR Green Reaction
Mix (TaKaRa, Dalian, China) according to the manufac-
turer’s instructions on an ABI PRISM 7900HT Detection
System (Applied Biosystems, Carlsbad, CA, USA). PCR condi-
tions were 95◦C for 10min and 40 cycles of 95◦C for 30 s,
60◦C for 30 s and 72◦C for 1min. PCR primers which were
designed using Primer3 Input (version 0.4.0) online software
(http://frodo.wi.mit.edu/) are listed in Table 1. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as a control
and the target gene expression was calculated using the Ct
comparative method.
WESTERN BLOT ANALYSIS
Protein extraction and immunoblot analysis were performed
according to procedures reported previously with minor mod-
ifications (Niagara et al., 2007). In brief, after corresponding
treatments, MSCs were rinsed twice with PBS and then were lysed
in ice-cold lysis buffer supplemented with protease inhibitors for
30min. Cell lysates were centrifuged at 14000 g for 30min at 4◦C
to remove cell debris. The protein concentrations were deter-
mined by the BCA Protein Assay (Bio-Rad, Berkeley, CA, USA).
The proteins were separated by 8–12% SDS-PAGE gels and trans-
ferred electrophoretically onto polyvinylidene fluoride (PVDF)
membranes (Bio-Rad, Berkeley, CA, USA). After non-specific
binding site was blocked with 5% non-fat milk, the membranes
Table 1 | Name and sequence of primer sets for real-time RT-PCR.
Gene name Primer sequence Gene ID Product size
GAPDH F 5′- gagacagccgcatcttcttg-3′ NM_017008.4 224
GAPDH R 5′- tgactgtgccgttgaacttg-3′
SIRT1 F 5′-cgccttatcctctagttcctgtg-3′ XM_003751934.1 137
SIRT1 R 5′-cggtctgtcagcatcatcttcc-3′
TERT F 5′-agtggtgaacttccctgtgg-3′ NM_053423.1 232
TERT R 5′-caaccgcaagactgacaaga-3′
TRF1 F 5′-taccaaactcaagccccatc-3′ NM_001012464.1 170
TRF1 R 5′-gcagcaaactcacatcgaaa-3′
TRF2 F 5′-agaagaaagcgagtgggtga-3′ NM_001108448.1 178
TRF2 R 5′-ttgtgagtcctgtggctctg-3′
RAP1 F 5′-gtgagccttggttggaatgt-3′ NM_001013143.1 219
RAP1 R 5′-cctggggaatgggatagttt-3′
TIN2 F 5′-aaaaccagcatcccacagtc-3′ NM_001006962.1 212
TIN2 R 5′-atggtaggcctgtgttcctg-3′
POT1 F 5′-cagattcggcagtcactcaa-3′ NM_001024322.1 188
POT1 R 5′-cttcaaaacggcacacaatg-3′
TPP1 F 5′-cagtgaccacccaggacttt-3′ NM_031357.1 246
TPP1 R 5′-caacaggtcccactccttgt-3′
were rinsed with PBST and incubated with primary antibody
(1:1000) overnight at 4◦C. After being washed with PBST, the
membranes were incubated for 1 h with appropriate HRP- conju-
gated secondary antibodies (1:5000) at room temperature. After
being washed with PBST, protein bands were detected with an
ECL kit (Millipore, Billerica, MA, USA) using the Gel Doc EZ
Imaging System and analyzed using Image Lab software (Bio-Rad,
Berkeley, CA, USA).
Mouse monoclonal anti-SIRT1 antibody, rabbit polyclonal
anti-P21 antibody and chicken polyclonal anti-P16 antibody
were obtained from Abcam (Abcam, Cambridge, UK). Mouse
monoclonal β-actin antibody, horseradish peroxidase (HRP)-
conjugated anti-mouse, anti-rabbit and anti-goat secondary anti-
bodies were obtained from Cell Signaling Technology (Beverly,
MA, USA). Goat polyclonal TPP1 antibody was purchased from
Santa Cruz (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
HRP-conjugated anti-chicken second antibody was from Thermo
Scientific (Thermo Fisher Scientific, Waltham, MA, USA).
IMMUNOFLUORESCENCE
The cells from various groups were fixed in 4% formaldehyde
at room temperature (R.T) for 10min and permeabilized in
0.5% Triton X-100 in PBS at R.T for 20min. After washing
with PBS, the cells were blocked with 5% bovine serum albu-
min (BSA) in PBS at R.T for 1 h and thereafter incubated with
primary antibody diluted 1:100 at 4◦C overnight. Then, after
washing with PBS again, the cells were reacted with according
secondary antibody (Abcam, Cambridge, UK) at R.T for 1 h. The
cells were restained with 4′-6-diamidino-2-phenylindole (DAPI)
(Invitrogen, Carlsbad, CA, USA). Fluorescent imaging was con-
ducted with a fluorescencemicroscope (Leica,Wetzlar, Germany).
Mouse monoclonal anti-gamma H2A.X (phospho S139) were
obtained from Abcam (Abcam, Cambridge, UK). Rabbit poly-
clonal anti-TRF2 antibody was purchased from Santa Cruz (Santa
Cruz Biotechnology, Santa Cruz, CA, USA).
ASSESSMENT OF SIRT1 ACTIVITY
SIRT1 deacetylase activity was measured in nuclear extracts from
MSCs using a histone deacetylase assay kit (AK-555), which
was purchased from BIOMOL (Plymouth Meeting, PA, USA)
(Solomon et al., 2006). Briefly, enzyme preparations were incu-
bated with 170μM NAD+ and 100μM p53 fluorogenic peptide
for 45min at 37◦C followed by incubation in developer for 15min
at 37◦C. The fluorescence intensity (excitation at 360 nm and
emission at 460 nm) was measured for 1 h every 5min using a
flurorescence plate reader (Molecular Devices, Sunnyvale, CA,
USA). SIRT1 deacetylase activity was expressed in relative fluo-
rescence units normalized by protein content.
MEASUREMENT OF TELOMERASE ACTIVITY
Telomerase activity was detected using the Telomeric Repeat
Amplication Protocol (TRAP) assay (Roche Applied Science,
Indianapolis, IN, USA) per the manufacturer’s instructions. In
brief, 2 × 105 MSCs were lysed in 200μl lysis regent and the cell
lysate was centrifuged at 16,000 g for 20min at 4◦C. 0.5μg of
cell extract was used for PCR reaction in a total volume of 50μl.
2.5μl of the amplification product was transferred for hybridiza-
tion and the ELISA assay. Telomerase activity was described as
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relative telomerase activity (RTA). Each group contained a nega-
tive and a high positive control. Telomerase activity was showed
as a percentage of the RTA of MSCs relative to the RTA of positive
control cells.
STATISTICS
All data are expressed as mean ± standard deviation (SD).
Analyses were implemented with GraphPad Prism 6.01 soft-
ware (San Diego, Calif). Comparisons between two groups were
tested using Student’s t-test. A value of P < 0.05 was considered
significantly different.
RESULTS
CHARACTERIZATION OF YOUNG AND AGED MSCs
The immunophenotype of MSCs from young and aged rats
were assessed by flow cytometry using specific cell surface anti-
gens. Both young and aged MSCs expressed the MSCs markers
CD29, CD44, CD73, CD90, and CD105 and were negative for
the markers CD31, CD34, and CD45 (Figure 1A). Similar plastic
adherence was observed for both MSCs that were isolated from
young and aged rats. Though young and aged MSCs both could
differentiate toward adipogenic and osteogenic lineage, the dif-
ferentiation potential of aged MSCs was impaired compared to
young counterparts (Figure S1).
Senescence-associated β-galactosidase (SA-β-gal) is universally
accepted as a marker for senescent cells (Kuilman et al., 2010;
Sikora et al., 2011; Campisi, 2013; Sikora, 2013). To ascertain
age-related cellular senescence alteration inMSCs, SA-β-gal activ-
ity was analyzed in MSCs obtained from young and aged rats at
the same passage. Compared with young counterparts, the per-
centage of β-gal positive cells and the staining intensity increased
significantly in MSCs from aged rats (Figures 1B–D). Arrested
growth is the defining characteristic of a senescent cell (Campisi,
2013), therefore, we assessed the proliferation rate for both
young and aged MSCs by Cell Counting Kit-8 (CCK-8) meth-
ods at the same passage. There were no significant differences in
the absorbance between the two groups during the first 3 days
(Figure 1E). However, the absorbance was significantly decreased
in aged MSCs compared with young counterparts 3 days later
(Figure 1E). These findings reveal the existence of age-related up-
regulated cellular senescence in MSCs, which is also evidenced by
a down-regulated cellular proliferation rate.
AGE ASSOCIATED ALTERATIONS OF SIRT1 EXPRESSION AND ACTIVITY
IN MSCs
To examine whether SIRT1 expression was altered in MSCs from
aged compared with young donors, we also analyzed SIRT1
expression in MSCs. Previous studies reported that SIRT1 was
expressed in MSCs from young donors (Yuan et al., 2012). Our
data demonstrated that not only the mRNA expression level of
SIRT1 in aged MSCs was three-fold lower than young MSCs
(Figure 1F), and the protein level of SIRT1 was also signifi-
cantly reduced in aged MSCs compared to young counterparts
(Figure 1G,H). Additionally, the enzyme activity of SIRT1 in aged
MSCs was 60% lower than that of the young MSCs (Figure 1I).
Thus, our data indicate that both the expression and the activity
of SIRT1 are significantly decreased in MSCs from aged donors.
SIRT1 MODULATES MSCs SENESCENCE AND PROLIFERATION
To further elucidate whether the age-related down-regulation of
SIRT1 expression and activity plays a role in MSC senescence, we
tested whether gain or loss of SIRT1 expression modulated the
senescence process of MSCs. We transduced young MSCs with
lentiviral vectors expressing SIRT1 shRNA or nonsense shRNA.
The transfection efficiency of lentivirus vector for genetically
modified MSCs was evaluated by enhanced green fluorescent
protein (EGFP). A representative EGFP expression is shown
in Figure S2. Reduction of SIRT1 protein levels in genetically
modified MSCs was evaluated by Western Blot (Figures 2A,B).
Inhibition of SIRT1 expression by shRNA in youngMSCs resulted
in a remarkable increase in percentage of β-gal staining posi-
tive cells and its overall intensity of staining (Figure 2D). In line
with this, a significantly reduction in cellular proliferation was
observed when SIRT1 was silenced in young MSCs (Figure 2F).
Next, we asked whether enhanced expression of SIRT1 in
aged MSCs affected cellular senescence and proliferation. Aged
MSCs were transduced with lentiviruses that expresses rat SIRT1
directed by a CMV promoter. The transfection efficiency of
lentivirus vector for genetically modified MSCs was evaluated
by EGFP (Figure S2). Increased expression of SIRT1 protein
in genetically modified MSCs was confirmed by Western Blot
(Figures 2A,C). Compared with lentivirus vector control, up-
regulated expression of SIRT1 in agedMSCs resulted in a decrease
in the percentage of β-gal positive cells and its intensity of stain-
ing (Figure 2E). In addition, the up-regulated SIRT1 protein level
was also associated with improved proliferation as shown by
changes in absorbance in the CCK8 assay, suggesting that reversed
SIRT1 could rescue the proliferation potential of aged MSCs
(Figure 2G).
SIRT1 MEDIATES SENESCENCE THROUGH MODULATION OF P16 AND
P21 EXPRESSION IN MSCs
P16 and P21 are both implicated as mediators of cellular senes-
cence (Kuilman et al., 2010). To explore whether P16 and P21 play
roles in SIRT1-mediated actions on MSC senescence, we evalu-
ated the expression of P16 and P21 at the protein level in young
and aged MSCs transduced with SIRT1 expression vectors. We
found that both P16 and P21 were significantly enhanced when
SIRT1 was silenced in young MSCs (Figures 3A,B). In contrast,
the expression of P16 and P21 were both significantly reduced
when SIRT1 was up-regulated in aged MSCs (Figures 3C,D).
These data indicate that the expression of P16 and P21 are both
negatively regulated by SIRT1 in MSCs.
SIRT1 PROTECT TELOMERE DNA DAMAGE IN MSCs
P16 and P21 have important roles in driving senescence in
response to DNA damage (Kuilman et al., 2010). In contrast,
DNA damage increases with aging in MSCs (Asumda and Chase,
2011) and SIRT1 can positively regulate DNA repair (Jeong
et al., 2007; Yuan et al., 2009; Luna et al., 2013). Thus, it is
logical to postulate that increased SIRT1 prevents age-related
DNA damage in MSCs. Therefore we assessed the DNA dam-
age response when SIRT1 was manipulated in young and aged
MSCs. The mean level of γ-H2AX foci, a marker of DNA dam-
age, was significantly increased when SIRT1 was silenced in
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FIGURE 1 | Characterization of young and aged MSCs. (A) Phenotypic
characterization of young and aged MSCs by flow cytometry.
Representative results showed that both young and aged MSCs were
both positive for CD29, CD44, CD73, CD90, and CD105 and negative for
CD31, CD34, and CD45. β-galactosidase (SA-β-gal) staining was
performed for young (B) and aged (C) MSCs, with percentage of
SA-β-gal positive cells shown in bar graph in (D). Cell proliferation
capability was also determined by Cell Counting Kit-8 (CCK-8) method
and time-course growth was plotted for both young and aged MSCs (E).
SIRT1 mRNA expression level was quantified by reverse-transcription
quantitative-PCR for young and aged MSCs with GAPDH used as a
control (F). Western blot was performed with a representative protein
bands shown in (G) and quantified in bar graph (H). SIRT1 activity was
also measured and expressed as fold changes shown in bar graph (I). All
the data are expressed as mean ± SD (three independent experiments,
n = 5 rats/group). ∗ implies P < 0.05, compared to young MSCs.
youngMSCs (Figures 4A,B); in contrast, γ-H2AX foci was signif-
icantly decreased in aged MSCs when SIRT1 was over-expressed
(Figures 4A,C). To further analyze whether SIRT1 action on
DNA damage was related to telomere changes, we performed
immunofluorescence staining of telomere induced foci (TIF)
assay. A cell was considered TIF positive if ≥50% of its γ-H2AX
foci merged with TRF2 (Alves et al., 2010; Brugat et al., 2010).
As shown in Figures 4A,D, TIF positive cells in SIRT1-depleted
young MSCs were significantly increased compared with mock-
transfected young MSCs (Figures 4A,D). On the other hand,
significant down-regulation of TIF positive cells was observed
when SIRT1 was enhanced in aged MSCs (Figures 4A,E). This
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FIGURE 2 | SIRT1 mitigates age-related senescence of MSCs. SIRT1
protein levels in genetically modified young and aged MSCs were evaluated by
Western Blot. Representative protein bands were shown in (A) and quantified
in bar graph (B,C). Representative images of SA-β-gal staining for both young
MSCs that were transfected with either mock- or shSIRT1-vectors (shown in
D(i) and D(ii), respectively) and aged MSC transfected with either empty
vector or SIRT1 overexpressing (shown in E(i) and E(ii), respectively), with
quantification shown in bar graphD(iii) and E(iii), respectively). Representative
time-course growth of young (mock- and sh-SIRT1) (F) and aged (vector- and
SIRT1-) (G)MSCs were also shown. Data are expressed as mean ± SD (three
independent experiments, n = 5 rats/group). ∗Implies P < 0.05, compared to
mock-young MSCs. #, P < 0.05, compared to vector-aged MSCs.
indicates that SIRT1 protects against DNA damage by modula-
tion of the function of telomeres. Thus, our data suggest that
SIRT1 decreased age-related DNA damage through modulation
of telomere function in MSCs.
SIRT1 MODULATES TELOMERASE ACTIVITY IN MSCs
Previous studies showed that telomere attrition could trigger
telomere dysfunction, activate DNA damage and consequently
induce cellular senescence (Palm and de Lange, 2008; Stewart
et al., 2012). Telomere attrition might be closely related to
impaired telomerase activity since telomere elongation is pri-
marily catalyzed by telomerase in MSCs (Serakinci et al., 2008).
Therefore we evaluated age-related alterations of telomerase
activity and telomere length in MSCs. We discovered that telom-
erase activity and telomere length were both compromised in
aged MSCs compared with young counterparts (Figures 5A,B),
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FIGURE 3 | SIRT1 positively regulates P16 and P21 expression in
MSCs. SIRT1 knockdown in young MSCs was associated with increases in
P16 and P21 expression, with representative protein bands shown in (A)
and quantified in a bar graph shown in (B). In contrast, SIRT1
overexpression in aged MSCs decreases P16 and P21 expressions.
Representative western blot images (C) and the quantitative analysis
results (D) were shown. Data are expressed as mean ± SD (three
independent experiments, n = 5 rats/group). ∗Implies P < 0.05, compared
to mock-young MSCs. #, P < 0.05, compared to vector-aged MSCs.
which was consistent with the age-associated decrease in SIRT1
expression. This raised the possibility that SIRT1 might have
a role in modulating telomerase activity and telomere length.
We next analyzed the telomerase activity and telomere length
changes when SIRT1 was manipulated in young and aged MSCs,
respectively. Telomerase activity was inhibited and induced when
SIRT1 was silenced in young (Figure 5C) or overexpressed in
agedMSCs (Figure 5D), respectively, which indicated that telom-
erase activity can be positively modulated by SIRT1. In addi-
tion, we also found that TERT expression at the mRNA level
was decreased when SIRT1 was inhibited in young MSCs and
was increased when SIRT1 was up-regulated in aged MSCs
(Figure S3). Surprisingly, however, no significant variations in
telomere length were observed when SIRT1 was either down-
regulated in young MSCs (Figure 5E) or up-regulated in aged
MSCs (Figure 5F). These data reveal that SIRT1 positively modu-
lates the expression and activity of telomerase although telomere
length was not significantly affected.
SIRT1 PROTECT TELOMERE FUNCTION THROUGH MODULATION OF
TPP1
In addition to telomere attrition, telomere dysfunction can also
activate the DNA damage response pathway (De Lange, 2005;
Palm and de Lange, 2008; Stewart et al., 2012). Mammalian
telomeres are bound by shelterin, a specialized complex com-
posed of six core proteins, i.e., TRF1, TRF2, RAP1, TIN2, POT1,
and TPP1. Shelterin plays an important role in determining the
structure of the telomere terminus, generation of t-loops, and
telomerase-based telomeric DNA synthesis (De Lange, 2005). It
FIGURE 4 | SIRT1 protects telomere DNA damage in MSCs.
Representative immunofluorescence images of young (mock- and shSIRT1-)
and aged MSCs (vector- and SIRT1) stained with γ-H2AX (Green), TRF2
(Red), and DAPI (Blue) (A). Quantitative analysis of γ-H2AX foci in young
(mock- and shSIRT1-) (B) and aged MSCs (vector- and SIRT1-) (C) were
shown. A cell was considered TIF positive if ≥50% of its γ-H2AX foci were
associated with TRF2 (as shown in merged image). Quantitative analysis of
TIF positive cells in young (mock- and shSIRT1-) (D) and aged MSCs (vector-
and SIRT1-) (E) were shown. Data are expressed as mean ± SD (three
independent experiments, n = 5 rats/group). ∗Implies P < 0.05, compared
to mock-young MSCs. #, P < 0.05, compared to vector-aged MSCs.
has been demonstrated that the impairment of one component of
shelterin negatively influenced shelterin-induced telomere main-
tenance and protection (De Lange, 2005; Palm and de Lange,
2008; Stewart et al., 2012), indicating that all components of shel-
terin are essential for telomere function. To explore the effect of
age on the expression of shelterin, we assessed the expression of
shelterin components in young and aged MSCs. We found that
all members of shelterin were decreased in aged MSCs compared
with their young counterparts (Figure 6A). To further elucidate
whether age-related alteration of SIRT1 expression was responsi-
ble for down-regulated expression of shelterin components, we
analyzed the mRNA expression levels of shelterin components
when SIRT1 was manipulated in young and aged MSCs. RT-PCR
results showed that inhibition of SIRT1 expression by shRNA
in young MSCs significantly enhanced the expression of TPP1
and RAP1 whereas the expression of TRF1, TRF2, TIN2, and
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FIGURE 5 | SIRT1 modulates telomerase activity, but not telomere
length in MSCs. Quantitative analysis of age-related alterations of
telomerase activity (A) and telomere length (B) in MSCs was shown.
Quantitative analysis of telomerase activity in young (mock- and shSIRT1-)
(C) and aged (vector- and SIRT1-) MSCs (D) was also shown. Quantitative
analysis of telomere length in young (mock- and shSIRT1-) (E) and aged
(vector- and SIRT1-) (F) MSCs was shown. No siginificant change in
telomere length was observed when SIRT1 was manipulated in young or
aged MSCs. Data are expressed as mean ± SD (three independent
experiments, n = 5 rats/group). ∗Signifies P < 0.05, compared to young
MSCs. #, P < 0.05, compared to mock-young MSCs. ∧, P < 0.05,
compared to vector-aged MSCs.
POT1 were not influenced (Figure 6B). On the other hand, forced
expression of SIRT1 in agedMSCs contributed to a significant up-
regulation of TPP1, POT1 and TIN2 expression without affecting
the expression level of TRF1, TRF2, and RAP1 (Figure 6C).
Thus, TPP1 is the only shelterin component that can be regu-
lated by both down- and up-regulation of SIRT1. Western blot
showed that TPP1 protein expression was consistent with its
changes in mRNA levels, demonstrating a decreased in young
MSCs when SIRT1 was silenced (Figures 6D,E) and an increase
in aged MSCs where SIRT1 was over-expressed (Figures 6D,F).
Taken together, these results show that SIRT1 may have a role
in modulating telomere shelterin and TPP1 might be a key tar-
get of SIRT1 mediated protection against age-related senescence
of MSCs.
DISCUSSION
In this study, our data demonstrated that silencing SIRT1 in
young MSCs inhibited TPP1 expression and telomerase activ-
ity and induce the DNA damage response, which is consistent
with an increase of cellular senescence and decreased cellular
proliferation. A reversal of these changes was observed in aged
MSCs with forced SIRT1 over-expression.
Tissue-specific changes of SIRT1 expression have been
reported during aging. For example, while SIRT1 expression
increased in skeletal muscle, liver, heart, kidney and lung (Koltai
et al., 2010; Braidy et al., 2011), it was significantly decreased
in hippocampus with aging (Quintas et al., 2012). Although a
previous study reported no significant difference in SIRT1 expres-
sion in MSCs obtained from 4-week-old and 15-month-old male
C57BL/6 mice (Li et al., 2011), our data is in sharp contrast
and clearly demonstrates significantly decreased SIRT1 expression
during aging of rodent MSCs. Although we cannot account for
this discrepancy, it might be related to mouse vs. rat or differences
in the experimental conditions. It has been shown that SIRT1
expression decreases with increased passage number of young
MSCs (Yuan et al., 2012); in results not shown we observed simi-
lar trends of SIRT1 expression in cultured aged MSCs. Therefore
cell passage and culture time in vitromay be a critical factor when
comparing different experimental groups. Thus, our data support
the notion that SIRT1 expression decreases with aging.
Previous studies demonstrated that cellular proliferation
capacity of MSCs is significantly compromised with aging
(Stolzing et al., 2008; Zhou et al., 2008; Efimenko et al., 2011;
Katsara et al., 2011; Alt et al., 2012). This change is tightly cor-
related with the increase in the percentage of the senescent cells
in the stem cell pool (Stolzing et al., 2008; Zhou et al., 2008; Alt
et al., 2012). In the current study, SA-β-gal, as a widely accepted
hallmark of senescent cells (Campisi, 2013; Sikora, 2013) was
induced whereas cellular proliferation ability was inhibited in
agedMSCs compared to youngMSCs. Moreover, down-regulated
SIRT1 expression in young MSCs resulted in an inhibited cellu-
lar proliferation and an increase in percentage of β-gal positive
cells. The relationship between β-gal positive cells and prolifer-
ation ability was also seen in aged MSCs where overexpressing
of SIRT1 promoted cellular proliferation and down regulated β-
gal positive cells. Thus, our data suggest that during aging, the
β-gal expression is closely associated with proliferation capability,
and importantly manipulation of SIRT1 expression can modulate
these biological processes. Thus, our data not only provide evi-
dence that SIRT1 is down-regulated during aging, but also that
SIRT1 plays a key role in senescence process of aged MSCs.
The expression of P16 and P21 is increased in aged MSCs
(Stolzing et al., 2008; Zhou et al., 2008; Alt et al., 2012) and in vitro
culture (Ksiazek, 2009). A reduction in P16 (Shibata et al., 2007)
or P21 (Yew et al., 2011) expression in MSCs can improve in vitro
cellular senescence and senescence-related changes. In an in vitro
study looking at senescent process in MSCs, Yuan and coworkers
(Yuan et al., 2012) observed that SIRT1 silencing leads to increases
in both P16 and P21 expression in adipose tissue-derived MSCs,
however only P16, but not P21, was enhanced in bone marrow-
derivedMSCs, suggesting that P16 and P21 are differentially regu-
lated during aging in MSCs isolated from different tissue sources.
Interestingly, our data showed that both P16 and P21 expression
are negatively correlated with SIRT1 expression in MSCs, indi-
cating that P16 and P21 are both involved in SIRT1 mediated
protection against DNA damage during MSCs senescence. Our
data thus further support the previous studies demonstrating that
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FIGURE 6 | SIRT1 positively modulates TPP1 expression in MSCs. (A)
Age-related changes in mRNA levels of each telomere shelterin
components including TRF1, TRF2, RAP1, TIN2, POT1, and TPP1 in
MSCs was quantified. The mRNA expression levels were quantified
when SIRT1 was manipulated in young (mock- and shSIRT1-) (B) and
aged (vector- and SIRT1-) MSCs (C). Representative immunoblot images
(D) and the quantitative analysis results (E,F) demonstrated changes in
TPP1 protein level in young (mock- and shSIRT1-) and aged (vector- and
SIRT1-) MSCs. Data are expressed as mean ± SD (three independent
experiments, n = 5 rats/group). ∗Implies P < 0.05, compared to young
MSCs. #, P < 0.05, compared to mock-young MSCs. ∧, P < 0.05,
compared to vector-aged MSCs.
SIRT1 can enhance DNA repair activity (Jeong et al., 2007; Li
et al., 2008; Yuan et al., 2009; Dobbin et al., 2013) which could be
attributed to SIRT1-induced deacetylation of histones and non-
histones, including histone H3 lysine 56 (H3K56) (Yuan et al.,
2009), class I histone deacetylase (HDAC1) (Dobbin et al., 2013),
Ku70 (Jeong et al., 2007), and WRN (Li et al., 2008). And the
changes in both P16 and P21 can reflect the effects of SIRT1 on
mediating age-related DNA damage of MSCs.
SIRT1 action on telomere length has been reported previ-
ously. The single-nucleotide polymorphism of SIRT1 gene has
significant influence on leukocyte telomere length (Kim et al.,
2012). Moreover, overexpression of SIRT1 in mice resulted in
significantly longer telomere whereas the deficiency of SIRT1
expression in mice contributed to a pronounced shorter telom-
ere length (Palacios et al., 2010), suggesting a critical regulatory
role of SIRT1 in controlling telomere length. Unexpectedly, how-
ever, no significant alteration in telomere length was observed
when SIRT1 expression was manipulated in young or aged MSCs
in our present study. This may be explained by the fact that the
limited cell culture time after SIRT1 manipulation is not suffi-
cient to induce obvious change in telomere length. Nevertheless,
telomerase activity was closely regulated by SIRT1 expression and
this is likely to play an important role in protecting against DNA
damage during the aging process. Interestingly, our further stud-
ies demonstrated that the telomere length of MSCs decreased
in SIRT1 knockdown, and increased in SIRT1 overexpression
respectively with a longer cell culture time (passage 8 after manip-
ulation) (Figure S4), indicating that the telomere length of MSCs
in vitro can be regulated by SIRT1 in a longer cell culture.
TPP1, a crucial component of shelterin, plays a critical role
in telomere maintenance since knockdown of TPP1 inhibits shel-
terin formation (O’Connor et al., 2006). Previous studies revealed
that the expression of TPP1 might be modulated by SIRT1. Chen
et al. (2011) have demonstrated that knockdown of SIRT1 in
hepatocellular carcinoma (HCC) cells inhibited TPP1 expression
and induced cellular senescence whereas up-regulated expres-
sion of TPP1 in SIRT1-depleted HCC cells improved cellular
senescence, strongly suggesting that TPP1 was closely involved in
SIRT1-mediated anti-senescence effects in HCC cells. In line with
this study, we also found that TPP1 was positively modulated by
SIRT1 in both young or aged MSCs. More importantly, in our
study TPP1 was the only component of shelterin that was manip-
ulated by either silencing or over-expressing SIRT1, and might
be the main mediator of SIRT1 action on age-related senescence
of MSCs. TPP1 does not contact with telomeric DNA directly,
instead, it forms a complex with POT1, another shelterin com-
ponent that binds the single-stranded overhang immediately at
the end of chromosomes. Therefore, the beneficial effects of TPP1
on telomere maintenance are mainly mediated through POT1.
On the other hand, TPP1 was indispensable for localization of
POT1 to the telomeres (Liu et al., 2004; Kibe et al., 2010) and for
maintaining the structure and function of the telomere. Further
research indicated that the interactive actions of TPP1/POT1 on
telomere maintenance also requires TIN2 (Kibe et al., 2010),
which is a crucial linkage connecting TPP1/POT1 complex to
TRF1 and TRF2 on the double-stranded telomeric DNA, sup-
porting the important roles played by each of these telomere
shelterin components (O’Connor et al., 2006). Here we showed
that POT1 and TIN2 were both up-regulated when SIRT1 was
over-expressed in aged MSCs, however, they did not show signif-
icant responses to a deletion of SIRT1 in young MSCs. Neither,
did we demonstrate any changes in TRF1 and TRF2 expressions
when SIRT1 expression was manipulated in MSCs. Interestingly,
we found that RAP1 expression at the RNA level only exhibited
a significant increase when SIRT1 was depleted in young MSCs,
but showed no significant changes when SIRT1 was overexpressed
in aged MSCs. It will be important to determine how these pat-
terns of changes in shelterin components are regulated by SIRT1
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activity and how this integrates with SIRT1 regulation of MSC
senescence.
To date, the influence of SIRT1 on telomerase activity is not
fully understood. The available information suggests that SIRT1
modulates telomerase in a cell type dependent manner. For exam-
ple, inhibition of SIRT1 in human BJT diploid fibroblasts and
HeLa cells leads to significant augmentation in telomerase activity
(Narala et al., 2008). In contrast, in mouse embryonic fibroblasts,
a proficient telomerase complex is present to maintain longer
telomeres only when SIRT1 was overexpressed (Palacios et al.,
2010). It has been shown that the regulation of SIRT1 on telom-
erase activity was mainly mediated by TERT (Narala et al., 2008).
Inhibition of SIRT1 in human BJT diploid fibroblasts and HeLa
cells leads to a small increase in TERT mRNA level; this mod-
ulation of TERT protein by SIRT1 was also observed in human
umbilical cord fibroblasts (Yamashita et al., 2012) and hematocel-
lular carcinomas (Chen et al., 2011). The present study showed
that SIRT1 knockdown in young MSCs induced TERT expres-
sion and telomerase activity whereas SIRT1 overexpression in
aged MSCs inhibited TERT expression and telomerase activity,
thus further suggesting that SIRT1 regulates age-related TERT
expression and telomerase activity in MSCs. In these studies we
did not test whether SIRT1 modulates post-translation regulation
of TERT, a regulation that has been reported previously (Narala
et al., 2008).
The regulatory role of the shelterin complex on telomerase
is attracting intensive interest. Results show that each shelterin
component exhibits a dampening effect on telomerase activ-
ity since inhibition of even one shelterin component promotes
telomerase-mediated telomere elongation (Palm and de Lange,
2008). Conflicting data also exist demonstrating that the shel-
terin components may have a promotive effect on telomerase for
which TPP1 was identified as a critical factor. It has been shown
that the effects of TPP1 on telomerase activity might depend
on the interaction between TPP1 and the G100 region of TERT
(Zaug et al., 2010). Considering that the expression of TPP1
could be positively modulated by SIRT1 in our experiments, it
is logical to reason that the positive role of SIRT1 on telomerase
activity might be mediated by TPP1. In addition, the beneficial
effects of TPP1 on telomere maintenance were mainly mediated
by POT1 through the TPP1-POT1 complex. This TPP1-POT1
association could not only up-regulate the activity and processiv-
ity of telomerase (Wang et al., 2007; Latrick and Cech, 2010) but
also modulate the access of telomerase to telomeric DNA (Xin
et al., 2007), indicating the critical role of POT1/TPP1 interaction
in telomerase activity. However, this notion was challenged by a
recent study that demonstrated that it is the TIN2, but not POT1,
that is necessary for recruitment of telomerase to telomeres by
TPP1(Abreu et al., 2010). Further studies are warranted to clarify
the role of TPP1, POT1, and TIN2 in SIRT1 action on telomerase
activity in MSCs during aging process.
In summary, we show that SIRT1 is biologically down-
regulated in aged MSCs and this parallels cellular senescence
and impaired proliferation capability. In addition, knockdown of
SIRT1 in young MSCs recapitulated the cellular senescence pro-
cess observed in aged MSCs, whereas overexpression of SIRT1
attenuated this biological aging process, leading to an enhanced
MSC proliferation. More importantly, we further demonstrated
that manipulation of SIRT1was closely associated with changes
in P16 and P21 expression suggesting that SIRT1 protects against
DNA damage and regulates telomere aging through TPP1. Our
results confirm an important role of SIRT1 in mitigating age-
related MSCs senescence and provide evidence for the notion
that age-associated MSCs senescence can be modulated by SIRT1.
Therefore SIRT1might be a novel target for reversing age-induced
alteration in MSCs.
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Figure S1 | Adipogenic and osteogenic potential of young and aged MSCs.
Representative morphology of young and aged MSCs, the adipogenic
differentiation stained with Oil red O while the osteogenic differentiation
identified by alkaline phosphatase staining.
Figure S2 | Representative images of EGFP expression in young [mock- (A)
and shSIRT1- (B)] and aged [vector- (C)and SIRT1- (D)] MSCs were shown.
Figure S3 | SIRT1 positively modulates telomerase reverse transcriptase
(TERT) expression in MSCs. Quantitative analysis of TERT in young (mock-
and shSIRT1-) (A) and aged (vector- and SIRT1-) (B) MSCs was shown.
Data are expressed as mean ± SD (three independent experiments, n = 5
rats/group). ∗, P < 0.05, compared to mock-young MSCs. #, P < 0.05,
compared to vector-aged MSCs.
Figure S4 | SIRT1 positively regulates the telomere length of MSCs in vitro
in a longer cell culture. Quantitative analysis of telomere length in young
(mock- and shSIRT1-) (A) and aged (vector- and SIRT1-) (B) MSCs was
shown. Data are expressed as mean ± SD (three independent
experiments, n = 5 rats/group). ∗, P < 0.05, compared to mock-young
MSCs. #, P < 0.05, compared to vector-aged MSCs.
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